Stay updated on CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial
Sign up to get notified when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.

Latest updates to the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page
- Check4 days agoChange DetectedAdded a Locations section for Maryland and updated the page revision to v3.3.3; the former Maryland Locations entry and HHS Vulnerability Disclosure link were removed, and the previous revision v3.3.2 was superseded.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 with no changes to study content or features; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check40 days agoChange DetectedThe page removed the government funding lapse notice, and the core study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check54 days agoChange DetectedNo changes to core study details (eligibility, endpoints, or schedule); observed differences are formatting and minor copy edits, and to avoid alerts for small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check83 days agoChange DetectedUpdated page version to v3.2.0 and added a government operating status disclaimer; removed the specific medical term 'B-cell chronic lymphocytic leukemia' from the content.SummaryDifference2%

- Check90 days agoChange DetectedUpdated terminology and taxonomy for leukemia/lymphoma and infections, and bumped revision to v3.1.0; older specific leukemia terms were removed in favor of broader or updated classifications.SummaryDifference0.7%

Stay in the know with updates to CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD19/CD22 CAR T Cells in Pediatric B Cell Malignancies Clinical Trial page.